Dr Geeta Badami, MD in Aberdeen, NJ - Pediatrics

Dr Geeta Badami, MD is a Pediatrics - Adolescent Medicine physician based in Aberdeen, New Jersey. Dr Geeta Badami is licensed to practice in New Jersey (license number 25MA03738300) and her current practice location is 601 Lloyd Rd, Aberdeen, New Jersey. She can be reached at her office (for appointments etc.) via phone at (732) 290-9192.

NPI number for Dr Geeta Badami is 1720057144 and her current mailing address is 601 Lloyd Rd, Aberdeen, New Jersey. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1720057144.

Contact Information

	Dr Geeta Badami, MD
	601 Lloyd Rd, Aberdeen, NJ 07747-1302
	(732) 290-9192
	Not Available

Physician's Profile

Full Name	Dr Geeta Badami
Gender	Female
Speciality	Pediatrics - Adolescent Medicine
Location	601 Lloyd Rd, Aberdeen, New Jersey
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1720057144
Provider Enumeration Date: 03/16/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Geeta Badami such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1720057144	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2080A0000X	Pediatrics - Adolescent Medicine	25MA03738300 (New Jersey)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Geeta Badami is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Geeta Badami, MD 601 Lloyd Rd, Aberdeen, NJ 07747-1302 Ph: (732) 290-9192	Dr Geeta Badami, MD 601 Lloyd Rd, Aberdeen, NJ 07747-1302 Ph: (732) 290-9192

News Archive

Passport introduces eCare NEXT intelligent revenue cycle platform

Passport Health Communications Inc., the Patient Access Experts, has introduced eCare® NEXT, an intelligent revenue cycle platform that automates the typically inefficient and often incomplete patient and payer data verification workflow within hospitals. The software can be implemented at any point in the access management workflow (e.g., scheduling, pre-registration or admission).

Folate levels decrease significantly during months with higher solar radiation

Thus, this team of scientists have determined a seasonal risk threshold among patients with folate deficiency, since, according to this study, folate levels decrease significantly in those months when solar radiation is higher.

Prospect for passage of final health care IT bill uncertain

Negotiations to reconcile House and Senate versions of legislation that would promote the implementation of health care information technology have not progressed, and prospects for passage of a final bill prior to the midterm elections are uncertain, according to congressional aides, CongressDaily reports (Lee, CongressDaily, 9/12).

Long-range alignment of gold nanorods for biomedical imaging technologies

Researchers from North Carolina State University have developed a simple, scalable way to align gold nanorods, particles with optical properties that could be used for emerging biomedical imaging technologies.

Mithridion's MCD-386CR receives Orphan Drug designation from FDA for PSP treatment

Mithridion, Inc., a privately-owned clinical stage drug development company focusing on serious Central Nervous System disorders, announces that the U.S. Food and Drug Administration has awarded Orphan Drug designation for MCD-386CR, its lead drug candidate, for the treatment of Progressive Supranuclear Palsy.

Dr Geeta Badami, MD - Pediatrics in Aberdeen, NJ